ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Genfit

Genfit (GNFT)

4.05
-0.015
( -0.37% )
Updated: 10:05:03

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
4.05
Bid
4.04
Ask
4.05
Volume
273,555
3.98 Day's Range 4.21
2.84 52 Week Range 5.79
Market Cap
Previous Close
4.065
Open
4.065
Last Trade
19
@
4.05
Last Trade Time
09:57:05
Financial Volume
-
VWAP
-
Average Volume (3m)
380,800
Shares Outstanding
49,834,983
Dividend Yield
-
PE Ratio
-6.92
Earnings Per Share (EPS)
-0.58
Revenue
38.68M
Net Profit
-28.89M

About Genfit

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Loos, Nord, Fra
Founded
1970
Genfit is listed in the Pharmaceutical Preparations sector of the Euronext with ticker GNFT. The last closing price for Genfit was 4.07 €. Over the last year, Genfit shares have traded in a share price range of 2.84 € to 5.79 €.

Genfit currently has 49,834,983 shares outstanding. The market capitalization of Genfit is 202.58 € million. Genfit has a price to earnings ratio (PE ratio) of -6.92.

GNFT Latest News

GENFIT: Positive Opinion from EMA Committee for Ipsen’s Iqirvo® (elafibranor) in Primary Biliary Cholangitis

Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), July 26, 2024 - GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving...

GENFIT : Avis positif du Comité des médicaments à usage humain (CHMP) pour l’Iqirvo® (élafibranor) d’Ipsen dans la Cholangite Biliaire Primitive

GENFIT : Avis positif du Comité des médicaments à usage humain (CHMP) pour l’Iqirvo® (élafibranor) d’Ipsen dans la Cholangite Biliaire Primitive Lille (France), Cambridge (Massachusetts...

GENFIT: Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial

GENFIT: Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland) July 9, 2024 – GENFIT (Nasdaq and...

GENFIT : Bilan semestriel du contrat de liquidité contracté avec le Crédit Industriel et Commercial

GENFIT : Bilan semestriel du contrat de liquidité contracté avec le Crédit Industriel et Commercial Lille (France), Cambridge (Massachusetts, États-Unis), Zurich (Suisse), le 9 juillet 2024 –...

GENFIT : Les nouvelles recommandations de pratique clinique de l'EASL-EASD-EASO pour la MASLD incluent NIS2+® comme outil-clé pour la détection de la MASH à risque  

GENFIT : Les nouvelles recommandations de pratique clinique de l'EASL-EASD-EASO pour la MASLD incluent NIS2+® comme outil-clé pour la détection de la MASH à risque   Lille (France...

GENFIT : Étape historique franchie avec l'approbation accélérée d'Iqirvo® d’Ipsen dans la Cholangite Biliaire Primitive par la FDA américaine

GENFIT : Étape historique franchie avec l'approbation accélérée d'Iqirvo® d’Ipsen dans la Cholangite Biliaire Primitive par la FDA américaine Iqirvo® (élafibranor) 80 mg comprimés...

GENFIT: Historic Milestone Achieved with U.S. FDA Accelerated Approval of Ipsen’s Iqirvo® for Primary Biliary Cholangitis

GENFIT: Historic Milestone Achieved with U.S. FDA Accelerated Approval of Ipsen’s Iqirvo® for Primary Biliary Cholangitis Ipsen’s Iqirvo® (elafibranor) 80 mg tablets receives U.S. FDA...

GENFIT présentera ses dernières avancées dans l'ACLF à l'EASL Congress™ 2024  

GENFIT présentera ses dernières avancées dans l'ACLF à l'EASL Congress™ 2024   Lille (France), Cambridge (Massachusetts, États-Unis), Zurich (Suisse), 29 mai 2024 - GENFIT (Nasdaq...

GENFIT : Résultats de l’Assemblée Générale Mixte du 22 mai 2024

GENFIT : Résultats de l’Assemblée Générale Mixte du 22 mai 2024 Quorum de 27,25% obtenu sur première convocation ayant permis d’approuver l’ensemble des projets de résolutions Lille (France...

GENFIT : Information financière du premier trimestre 2024

GENFIT : Information financière du premier trimestre 2024 Lille (France), Cambridge (Massachusetts, États-Unis), Zurich (Suisse), le 14 mai 2024 – GENFIT (Nasdaq et Euronext : GNFT), société...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.14-3.341288782824.194.213.9151771314.02552546DE
40.359.459459459463.74.243.472213013.96037023DE
120.83525.97200622083.2155.793.2153808004.383686DE
260.338.870967741943.725.793.0252458124.13122358DE
520.55515.87982832623.4955.792.842500563.74277513DE
1560.72421.76788935663.3265.792.7461968453.78782879DE
260-11.95-74.68751620.962.7463077346.16935398DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
WINTWindtree Therapeutics Inc
$ 7.22
(119.45%)
26.54M
BFIBurgerFi International Inc
$ 0.3551
(66.64%)
40.57M
RGCRegencell Bioscience Holdings Ltd
$ 15.17
(66.52%)
629.62k
SGMOSangamo Therapeutics Inc
$ 1.015
(51.04%)
39.35M
CREVCarbon Revolution Public Ltd
$ 8.86
(43.60%)
5.83M
TANHTantech Holdings Ltd
$ 0.2406
(-50.89%)
3M
NMHINatures Miracle Holding Inc
$ 0.2078
(-46.96%)
3.96M
DXCMDexCom Inc
$ 65.26
(-39.49%)
14.16M
POAIPredictive Oncology Inc
$ 1.34
(-28.34%)
3.25M
PMNProMIS Neurosciences Inc
$ 1.47
(-27.14%)
5.59M
SLNASelina Hospitality PLC
$ 0.04455
(18.48%)
163.16M
NVDANVIDIA Corporation
$ 114.21
(1.72%)
59.62M
VWEVintage Wine Estates Inc
$ 0.09005
(28.83%)
51.76M
BFIBurgerFi International Inc
$ 0.3551
(66.64%)
40.57M
SGMOSangamo Therapeutics Inc
$ 1.015
(51.04%)
39.35M

Discussion

View Full Feed
MetaMonster MetaMonster 5 minutes ago
Hang on to every share, The stage is set
RNAZ
shurtha2000 shurtha2000 5 minutes ago
HSCS $4.14
HSCS
LVerstee LVerstee 5 minutes ago
I have been asked to wait until after the newly promised payment date. I will comply with this request. However, if the payments are not received by then, I will proceed to post the zip file on a torrent site.

This has to end.
ITUP
oilin07 oilin07 5 minutes ago
Most undervalued stock on otc
BLLB
DR_rugby DR_rugby 5 minutes ago
Did ya get the memo ??

Enough said

GLTA
GME
oilin07 oilin07 5 minutes ago
Could easily see a move towards .05!!!
BLLB
Huggy Bear Huggy Bear 5 minutes ago
LOLOLOLOL, that was some buckeye analysis no doubt.
AABB
Nebuchadnezzar Nebuchadnezzar 5 minutes ago
not enough buying though

NVDA trades $25-$50 billion per day

if people really were buying this like crazy it would run 500% in one day with ease
NVDA
louieforpar louieforpar 5 minutes ago
The loser rapists comment at deposition. What he really feels about women.



https://www.google.com/url?q=https://amp.cnn.com/cnn/2024/02/01/politics/roberta-kaplan-donald-trump-deposition-maralago&sa=U&sqi=2&ved=2ahUKEwiUm-bJpcKHAxW5rYkEHSX0D5AQFnoECD0QAQ&usg=AOvVaw2MX
Jaxxm Jaxxm 6 minutes ago
The Party hasn't started yet when hits multi dollars
BFI
Carjockey2 Carjockey2 6 minutes ago
Can I get an Amen!!!

$HIRU ~This morning was a key reversal after three red days with an amazing amount of buying pressure for anything under .003 which all got gobbled up fast and there were many of us that didn't get our bids filled! Too many catalysts to look forward to that is giv
HIRU
New Day New Day 6 minutes ago
New to The Street TV Announces its Four Business Guest Interviews, Episode 581, Airs as Sponsored Programming on Bloomberg TV, Saturday, July 27, 2024, at 6:30 PM ET

"Game Changers" segment The Sustainable Green Team, Ltd.'s (OTC: SGTM) ($SGTM)
SGTM
mzasif mzasif 6 minutes ago
Sad to see a ChartMASTER prediction going so wrong...it is time for a name change to ChartLOSER >>> 😆
HIRU
PotsandPans420 PotsandPans420 6 minutes ago
NEW 52 WEEK HIGH
LCTC
glenn1919 glenn1919 6 minutes ago
BFI....................................................https://stockcharts.com/h-sc/ui?s=BFI&p=W&b=5&g=0&id=p86431144783
BFI
CaptBeer CaptBeer 6 minutes ago
https://x.com/GeoWizz_/status/1816839524481142826
AMRN
DR_rugby DR_rugby 6 minutes ago
Utoh those meddling kids did it again

https://www.sec.gov/files/litigation/complaints/2024/comp-pr2024-89.pdf

Hahaha

GLTA
GME
StockSeedGems2143 StockSeedGems2143 6 minutes ago
Looking good. Getting ready for loading zone.
TMMI
KeepItRealistic KeepItRealistic 7 minutes ago
Good question 🤷‍♂️
DBGI
work-n-hard work-n-hard 7 minutes ago
SGMO: Great Morning & More to come.
SGMO
Fatsachs Fatsachs 7 minutes ago
That would be amazing if they could do that!
DFCO
PonkenPlonken PonkenPlonken 7 minutes ago
wants to
KITT
Viewmont Viewmont 7 minutes ago
Thank you! Amen!
HIRU
jedijazz jedijazz 7 minutes ago
$CATV on Marketscreener #Undervalued #Trip Category V Biotech, Inc. Announces Letter of Intent to Acquire Genetic Networks, Expanding into Biotech Sector @catvbiotech
https://marketscreener.com/quote/stock/4CAE-TVIN0-13149234/news/Category-V-Biotech-Inc-Announces-Letter-of-Intent-to-Acquire-G
CATV
jedijazz jedijazz 7 minutes ago
$CATV on Marketscreener #Undervalued #Trip Category V Biotech, Inc. Announces Letter of Intent to Acquire Genetic Networks, Expanding into Biotech Sector @catvbiotech
https://marketscreener.com/quote/stock/4CAE-TVIN0-13149234/news/Category-V-Biotech-Inc-Announces-Letter-of-Intent-to-Acquire-G
CATV

Your Recent History

Delayed Upgrade Clock